Key Highlights

● Rocket Lab shares fell 7.98% to close at $50.84 on October 16.

● The consensus 12-month price target is $102.26, implying about 101.14% upside.

● Analysts are split 17 Buy, 4 Hold, and 0 Sell on the stock.

● Targets range from $64 to $150 across 21 analysts.

Rocket Lab Corporation (NASDAQ:RKLB) closed at $50.84 on October 16, 2026, according to market data. The consensus mean analyst price target, from 21 analysts, is $102.26, which sits 101.1% above the latest price (+101.14%). The shares dropped 7.98% on 16 October, and several brokers cut their targets in the same two-day window.

What Is the Latest Analyst Price Target?

The mean target is $102.26 and the median is $105.00. The highest target is $150 and the lowest is $64, so the range between the most optimistic and most cautious forecasts is wide. If the consensus proves accurate, the implied move from the latest close would be +101.1%. Price targets are forecasts, usually set with a 12-month horizon, not guarantees, and they are frequently revised as conditions change. Figures reflect market data in mid-October 2026, and other data providers may show slightly different numbers because of differing coverage and update times.

What Are Analysts Saying?

The consensus rating is Buy, with a split of 17 Buy, 4 Hold, 0 Sell. Recent actions include the following. Needham maintained Buy at $120 and Citizens JMP maintained Buy while cutting its target from $130 to $90 on October 16, 2026. On 15 October Goldman Sachs maintained Hold and cut its target from $75 to $67, Stifel maintained Buy at $132, and Clear Street maintained Buy while cutting its target from $129 to $105.

Together, these updates show how individual brokers are adjusting their views, and they should be read as snapshots rather than a settled verdict.

What Could Help the Stock Reach the Price Target?

The consensus target suggests potential if conditions develop favourably. On the supportive side, no analyst rates the stock Sell, and even the lowest target of $64 is above the current price. Several brokers retain Buy ratings with targets above $100. Stronger-than-expected results, positive guidance or an improving macroeconomic backdrop could also lead analysts to maintain or raise their forecasts, though none of these outcomes is certain.

What Could Prevent the Stock Reaching the Target?

There are also reasons for caution. The shares fell 7.98% on 16 October, and the cluster of target cuts (Citizens JMP, Goldman Sachs, Clear Street) suggests analysts are reassessing their assumptions. The consensus is roughly double the share price, so targets may continue to be revised toward the market. The stock is likely to remain volatile. Analyst forecasts can prove wrong, and unexpected company developments, weaker demand, cost pressures or a broader market sell-off could all push the shares away from the consensus level. A target is only an estimate of where analysts think the shares might trade, not a prediction that they will get there.

What Should Investors Watch Next?

Investors may wish to follow the company's next quarterly results and any change in guidance, as well as further target revisions from the brokers named above. Movements in the consensus mean, the balance of Buy, Hold and Sell ratings, and the share price relative to the consensus will all be useful indicators of shifting sentiment.

A Gap That Tests Patience

With a latest close of $50.84 and a consensus mean target of $102.26, the consensus target suggests an implied +101.1% move from the October 16, 2026 price. Because analysts disagree, as the range of $64 to $150 shows, the forecast should be treated as one input among many.